The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
dihydrorobinetin ID: ALA1163000
PubChem CID: 17751005
Max Phase: Preclinical
Molecular Formula: C15H12O7
Molecular Weight: 304.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: 3,7,3',4',5'-Pentahydroxyflavanone | Dihydrorobinetin | Dihydrorobinetin|3,7,3',4',5'-Pentahydroxyflavanone|SCHEMBL432879|CHEMBL1163000
Canonical SMILES: O=C1c2ccc(O)cc2O[C@@H](c2cc(O)c(O)c(O)c2)[C@@H]1O
Standard InChI: InChI=1S/C15H12O7/c16-7-1-2-8-11(5-7)22-15(14(21)12(8)19)6-3-9(17)13(20)10(18)4-6/h1-5,14-18,20-21H/t14-,15+/m1/s1
Standard InChI Key: VSJCDPYIMBSOKN-CABCVRRESA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8926 1.4990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 -1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4908 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1929 0.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8904 2.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1883 3.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 3.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5309 0.9045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5268 3.6045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1865 4.9510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
7 6 1 0
5 6 2 0
5 8 1 0
7 10 1 0
8 9 1 0
9 10 1 0
10 11 1 1
9 12 1 6
8 13 2 0
2 14 1 0
16 11 2 0
11 17 1 0
15 16 1 0
15 19 2 0
17 18 2 0
18 19 1 0
15 20 1 0
19 21 1 0
18 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.25Molecular Weight (Monoisotopic): 304.0583AlogP: 1.19#Rotatable Bonds: 1Polar Surface Area: 127.45Molecular Species: NEUTRALHBA: 7HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.66CX Basic pKa: ┄CX LogP: 1.17CX LogD: 0.97Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.50Np Likeness Score: 2.07
References 1. Lale A, Herbert JM, Augereau JM, Billon M, Leconte M, Gleye J.. (1996) Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes., 59 (3): [PMID:8882428 ] [10.1021/np960057s ] 2. Lee S, Woo Y, Shin SY, Lee YH, Lim Y.. (2009) Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression., 19 (8): [PMID:19307119 ] [10.1016/j.bmcl.2009.03.017 ] 3. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825 ] [10.1016/j.bmc.2012.09.040 ]